Literature DB >> 34149223

Rifampicin as an Adjunct to Ursodeoxycholic Acid for Treating Severe Refractory Intrahepatic Cholestasis of Pregnancy in a Patient with Elevated Bilirubin.

Vidushi Kulshrestha1, Shinjini Narang1, Neerja Bhatla1.   

Abstract

Entities:  

Year:  2020        PMID： 34149223      PMCID： PMC8167008          DOI： 10.1007/s13224-020-01388-4

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN： 0975-6434


× No keyword cloud information.
  4 in total

1.  Adjuvant Use of Rifampin for Refractory Intrahepatic Cholestasis of Pregnancy.

Authors:  James Liu; Amanda M Murray; Erin B Mankus; Kayla E Ireland; Ometeotl M Acosta; Patrick S Ramsey
Journal:  Obstet Gynecol       Date:  2018-09       Impact factor: 7.661

2.  Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.

Authors:  Hanns-Ulrich Marschall; Martin Wagner; Gernot Zollner; Peter Fickert; Ulf Diczfalusy; Judith Gumhold; Dagmar Silbert; Andrea Fuchsbichler; Lisbet Benthin; Rosita Grundström; Ulf Gustafsson; Staffan Sahlin; Curt Einarsson; Michael Trauner
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

3.  Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Jenny Chambers; Rshmi Khurana; Elisabeth Wikstrom Shemer; Winnie Sia; Dalvinder Mandair; Elwyn Elias; Hanns-Ulrich Marschall; William Hague; Catherine Williamson
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2015-03-28       Impact factor: 2.435

4.  Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study.

Authors:  Victoria Geenes; Lucy C Chappell; Paul T Seed; Philip J Steer; Marian Knight; Catherine Williamson
Journal:  Hepatology       Date:  2014-02-26       Impact factor: 17.425
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.